Stage III Ovarian Epithelial Cancer Completed Phase 3 Trials for Trimetrexate (DB01157)

IndicationStatusPhase
DBCOND0028510 (Stage III Ovarian Epithelial Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs